Litcius/Paper detail

Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors

Margaret Ann Kreher, Sailesh Konda, Mary Margaret B. Noland, María Isabel Longo, Rodrigo Valdés‐Rodríguez

2022Journal of the American Academy of Dermatology56 citationsDOI

Topics & Concepts

MedicineSkin cancerTofacitinibImmunosuppressionEfalizumabAbataceptImmunologyOncologyCancerInternal medicineInfliximabRheumatoid arthritisTumor necrosis factor alphaRituximabLymphomaNonmelanoma Skin Cancer StudiesPolyomavirus and related diseasesCutaneous lymphoproliferative disorders research